期刊文献+

替米沙坦对晚期血吸虫肝病患者肝纤维化程度和门静脉血流动力学的影响 被引量:5

原文传递
导出
摘要 肝纤维化是血吸虫病患者发病以及导致严重并发症的病理学基础,若能减轻乃至逆转肝纤维化,就能有效地改善血吸虫肝病患者的预后。阻断血管紧张素Ⅱ1型受体(angiotensinⅡtype1receptor,ATlR)后,代偿期肝硬化患者门静脉压力下降,血清肝纤维化指标水平亦降低。
作者 郭文建 章鹏
出处 《中华消化杂志》 CAS CSCD 北大核心 2012年第11期769-771,共3页 Chinese Journal of Digestion
基金 苏州市科技发展计划(SYS2010060)
  • 相关文献

参考文献7

  • 1Debernardi-Venon W, Martini S, Biasi F, et al. AT1 receptor antagonist Candesartan in selected cirrhotic patients: effect on portal pressure and liver fibrosis markers. J Hepatol, 2007, 46:1026-1033.
  • 2Zhou XN, Bergquist R, Leonardo L, et al. Schistosomiasis japonica control and research needs. Adv Parasitol, 2010,72: 145-178.
  • 3Georgescu EF. Angiotensin receptor blockers in the treatment of NASH/NAFLD: could they be a first-class option?. Adv Ther, 2008,25 : 1141-1174.
  • 4Jin H, Yamamoto N, Uchida K, et al. Telmisartan prevents hepatic fibrosis and enzyme-altered lesions in liver cirrhosis rat induced by a choline-deficient L-amino acid-defined diet. Biochem Biophys Res Commun, 2007,364 : 801-807.
  • 5Hou XY, Ellis MK, McManus DP, et al. Diagnostic value of non-invasive bio-markers for stage-specific diagnosis of hepatic fibrosis in patients with advanced schistosomiasis japonica. Int J Parasitol,2011,41:325-332.
  • 6Parkes J, Roderick P, Harris S, et al. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease. Gut, 2010,59: 1245-1251.
  • 7Tox U, Steffen HM. Impact of inhibitors of the Reninangiotensin-aldosterone system on liver fibrosis and portal hypertension. Curr Med Chem, 2006,13: 3649-3661.

同被引文献23

引证文献5

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部